Investment Criteria   Investment Focus Nexus invests in medical technology companies and in life science companies in various stages of development, including medical devices, diagnostics, biotechnology, specialty pharmaceutical and drug discovery tools. We prefer to lead our investment syndicates and to work in a hands-on manner with our portfolio companies, committing multiple partners to each investment. We are active globally and will consider investments in the US, Europe, the Middle East and Asia, especially in companies seeking either to expand outside their region or to attract companies into their region.   Management/Entrepreneurs We believe that the strength and background experience of the management team will almost always define a company's opportunity for success. We look for proven management teams that are passionately driven to succeed.   Value-Added Investors We pride ourselves in being a value-added investor by staying actively involved with our portfolio companies. We will work closely with portfolio companies to identify and attract executive talent, board members, advisors, and consultants. Additionally, we can assist in devising market strategy, entrepreneurial management, and business development. We have a history of helping our companies expand their network with introductions to institutional fundraising sources, marketing and development partners and strategic customers. Our international network of corporate and financial contacts forged over 30 years is made available to our portfolio companies to accelerate their growth and their expansion into foreign markets.   Investment Assessment Our detailed assessment of investment candidates includes the evaluation of many profiles, including: The company's products and technologies and their market opportunity; Intellectual property, legal issues, regulatory status and remaining pathway; Risk factors and means of overcoming risks; Future requirements for human and financial resources; Opportunities for adding value, including synergistic M&A opportunities; Exit strategy and timetable for achieving liquidity. Submission of Business Plans We invite the submission of executive summaries and business plans for review. Materials may be sent to . While we observe a policy of confidentiality regarding such materials, submissions should not be construed as our having signed a confidentiality agreement. We look forward to reviewing appropriate opportunities with you.